Desbutal
Desbutal was a combination drug composed of two active ingredients: methamphetamine and pentobarbital. It was used primarily in the mid-20th century for its stimulant and sedative effects. The drug was prescribed for various conditions, including depression, anxiety, and narcolepsy.
Composition and Mechanism of Action
Desbutal combined the stimulant properties of methamphetamine with the sedative effects of pentobarbital. Methamphetamine is a potent central nervous system (CNS) stimulant that increases the release of neurotransmitters such as dopamine and norepinephrine, leading to increased alertness, concentration, and energy. Pentobarbital, on the other hand, is a barbiturate that acts as a CNS depressant, producing sedative and hypnotic effects by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA).
Medical Uses
Desbutal was prescribed for a variety of conditions:
- Depression: The stimulant component helped alleviate symptoms of depression by increasing energy and mood.
- Anxiety: The sedative component helped reduce anxiety and promote relaxation.
- Narcolepsy: The stimulant component helped manage excessive daytime sleepiness and sudden sleep attacks.
Side Effects and Risks
The combination of a stimulant and a sedative in Desbutal posed significant risks, including:
- Addiction: Both methamphetamine and pentobarbital have high potential for abuse and dependence.
- Cardiovascular issues: The stimulant effects of methamphetamine could lead to increased heart rate and blood pressure.
- Respiratory depression: The sedative effects of pentobarbital could cause respiratory depression, especially in high doses.
Regulation and Discontinuation
Due to the high potential for abuse and the availability of safer alternatives, Desbutal was eventually discontinued. The Controlled Substances Act and other regulatory measures led to stricter controls on the prescription and distribution of both methamphetamine and pentobarbital.
Related Pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
